| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |